Octant Bio: Funding, Investors & Team (Oct 2026)
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
Octant Bio has raised $110M across 2 funding rounds on record, the most recent a Series B of $80.0M announced in Apr 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Octant Bio Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Octant Bio Funding Rounds
Octant Bio raised $30.0M in an undisclosed round announced in May 2020.
1.9 years later, a Series B of $80.0M was announced in Apr 2022.
Octant Bio Founders and Leadership Team
Contact details for the Octant Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Octant Bio Funding Compared to Other Biotechnology Startups
Octant Bio's latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Octant Bio in Biotechnology and Los Angeles
Companies Similar to Octant Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Octant Bio Funding FAQs
What does Octant Bio do?
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
How much funding has Octant Bio raised?
Octant Bio has raised $110M across 2 rounds on record. The most recent is a Series B of $80.0M announced in Apr 2022.
When did Octant Bio last raise funding?
Octant Bio's most recent funding round on record is a Series B of $80.0M, announced in Apr 2022.
Who is the CEO of Octant Bio?
Sri Kosuri is listed as CEO at Octant Bio.
Where is Octant Bio headquartered?
Octant Bio is based in Los Angeles, California, United States.
How many employees does Octant Bio have?
Octant Bio is in the 51-100 employee band.
How does Octant Bio's funding compare to other Biotechnology startups?
Octant Bio's latest round of $80.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Octant Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Octant Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.